Healthtech Startups

Harbinger Health develops early cancer detection technology through its Harbinger HX platform, which embeds developmental biology into biomarker discovery, assay design, and model training to detect faint biological signals of early cancer in real-world samples. The company builds tools for oncology and cancer management.

1 investor

Harbor provides electronic data capture (EDC) software for clinical trial teams, designed to reduce data entry time and enable remote monitoring to improve data quality and accelerate trial timelines.

1 investor

Harbor provides sleep training and infant care services for parents and families seeking better sleep and wellness support.

1 investor

Harbor MedTech develops collagen-based medical devices and bioimplants for surgical wound healing and tissue regeneration. The company's BriDGE technology platform produces products for orthopedic, general surgical, and chronic wound care applications.

1 investor

Harmar manufactures mobility and accessibility products such as stair lifts, elevators, and vehicle modification equipment, distributed through a dealer network. Its products serve people with disabilities and limited mobility, including home accessibility and transportation applications.

1 investor

Harmonize builds AI agents that handle routine phone calls, messages, and faxes for private medical practices, offloading administrative communication tasks from staff. The product targets independent healthcare providers.

1 investor

Harmony provides agentic automation for healthcare patient intake operations, working inside existing tools like EHR systems, fax, mail, and payer portals to process referrals, extract documents, and handle repetitive intake tasks. It targets healthcare provider teams, offering medically aware document intelligence (ICD/HCPCS, LCD/NCD) with enterprise-grade security and compliance features.

1 investor

Harmony Pharma Group provides CMC (chemistry, manufacturing, and controls) consulting for small molecule and antibody drug conjugate development, offering technical, regulatory, and quality strategy from early bench work through clinical stages to commercialization. It also supports implementation of these plans at CDMOs on behalf of pharmaceutical clients.

1 investor

Harp Diagnostics is developing Harp 360, a remote patient monitoring platform for inflammatory bowel disease (Crohn's disease and ulcerative colitis) and other GI conditions, combining a home sample collector with an automated cloud-connected testing system. The platform serves IBD patients and their treating physicians as a decision-support and disease-management tool aimed at achieving prolonged remission.

1 investor

Harvard Bioscience manufactures and supplies life science research tools and laboratory equipment for academic institutions and pharmaceutical companies. The company serves the research and development market with advanced instrumentation and solutions.

1 investor

HiRO is a full-service global contract research organization (CRO) that manages clinical trials for biotech companies, integrating regulatory strategy, clinical data science, clinical operations, medical monitoring, and quality into a single execution model. It operates across regions including North America and APAC and serves biotech sponsors developing drugs and therapies across therapeutic areas such as oncology and rare diseases.

1 investor

Hashed Health is a venture firm that combines healthcare operators, technologists, and entrepreneurs to develop practical businesses addressing complex healthcare challenges. The firm focuses on care delivery, digital health, and emerging technologies.

1 investor

Hausen manufactures molecular diagnostic tests for detecting HPV, respiratory pathogens, and leukemia fusion genes using real-time PCR technology for clinical and laboratory use.

1 investor

Haut.AI analyzes skin condition from selfies using proprietary algorithms and recommends personalized skincare products and routines. The platform serves consumers seeking tailored skincare recommendations based on individual skin assessments.

1 investor

Havea Group develops natural and organic health and wellness products sold to consumers through its portfolio of brands. The company operates in the natural health and consumer wellness industry with a stated focus on sustainability.

1 investor

Haven provides virtual, specialist-led treatment for headache and migraine patients, offering initial evaluations, custom attack plans, medication management, IV care, preventive injections, and referrals to in-person care. It serves adults in California and works in-network with most major PPO, EPO, Medicare, and TRICARE plans, as well as offering a cash pay option.

1 investor

HAVEN offers connected monitoring and automation systems for residential indoor air quality, managing ventilation, filtration, humidity, and radon through professional installation and ongoing software support.

1 investor

Hawthorne Health operates a network of 12 community-based clinical research sites and offers in-home visits to conduct clinical trials, aiming to improve patient enrollment, retention, and protocol-compliant data. It serves study sponsors across therapeutic areas including cardiovascular, dermatology, immunology, neurology, and rare disease.</parameter> <parameter name="founders">[]

1 investor

Haypp Group is an e-commerce company selling nicotine pouches and snus online, serving consumers shifting from combustible tobacco to smokeless products. It operates as a leading online retailer in the nicotine pouch and snus category.

1 investor

HaystackAnalytics develops clinical genomics products for diagnostic labs and hospitals to deliver accurate and personalized diagnostics. The company specializes in genomics-based infectious disease diagnostics, particularly for tuberculosis detection in India.

1 investor

HBF is a not-for-profit health fund offering private health insurance, including single, couple, and family cover as well as Overseas Visitors Health cover. It serves individuals and families in Australia.

1 investor

Kaipu (Kepu) operates a network of medical laboratories and inspection centers across China and Hong Kong, providing clinical diagnostic testing services, including infectious disease and COVID-19 testing. The company runs facilities in numerous cities and supports government public health and epidemic response efforts.

1 investor

HBOX Therapies is a medical device company developing the MiRA system, an extracorporeal gas exchange device that oxygenates blood and removes carbon dioxide independently of the lungs as a less invasive alternative to mechanical ventilation. It targets patients with acute respiratory failure in intensive care units, using proprietary technologies including an artificial lung, a hyperbaric gas management system, and a novel blood pump.

1 investor

hc1 offers hc1 IQ, an AI-based platform that turns laboratory and diagnostic data into clinical, operational, supply chain, and market-growth intelligence for health systems and providers. It integrates with LIS, EHR, and supply chain systems to identify care gaps, optimize lab operations, reduce testing and supply costs, and support outreach and client retention.

1 investor